Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abrupt versus tapered discontinuation of long-term hormone therapy in postmenopausal women
2017-000328-85Phase 4Terminated
- Sponsor
- Helsinki University Hospital
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of estradiol valerate in vasomotor symptoms and menopause (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Flow-mediated dilation. Started Mar 2017; status: terminated.
02
Drugs
estradiol valerate
03
Conditions
vasomotor symptomsmenopause
Beyond the preview
Go deeper on 2017-000328-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000328-85.